A monoclonal antibody directed against the BK virus large T-antigen (clone BK.T-1) has previously been used to evaluate BKV-T antigen (BKV-TAg) expression. However, our experience showed a consistent reactivity to uninfected human, but not rodent cells and tissues. Using immunoprecipitation, Western analysis, amino acid sequencing and end-point dilution analysis, we analysed the BK.T-1 antibody reactivity and identified the bound cellular protein. The results clearly show that the antibody recognizes the large subunit (Ku86) of the Ku autoantigen, the regulatory component of the DNAPKcs. We also demonstrated that the antibody retained its original reactivity in BKV-TAg transformed hamster kidney cells. The cross-reaction of the BK.T-1 antibody suggests a possible similarity between BKV-TAg and Ku86, but makes the antibody unsuitable for studies of BKV large T-antigen in the human cells.
Introduction
Polyomavirus and simian virus 40 (SV40) have served as powerful tools to identify key cellular regulatory proteins and to discern the mechanisms by which these proteins exert their biological effects. So far, two human polyomaviruses (hPy) have been described, BK virus (BKV) and JC virus (JCV). Both hPy have been associated with human disease. JCV is associated with Progressive Multifocal Leukoencephalopathy (PML) and BKV is associated with hemorrhagic cystitis. A possible role for these viruses in human cancer has also been suggested (Imperiale, 2000 and references therein) .
SV40, BKV and JCV are potentially oncogenic, capable of transforming many mammalian cells in culture and of inducing tumors in animal models. The oncogenic properties of these viruses have been demonstrated to be mediated through the action of the large tumor (T)-antigens (TAg), multifunctional regulatory proteins responsible for both viral regulation and required for cellular transformation. TAg binds to a number of cellular proteins, such as the tumor suppressor p53, the retinoblastoma tumor suppressor family and DNA polymerase a-primase. TAg also exhibits DNA binding properties and ATPdependent DNA helicase activity (Fanning and Knippers, 1992) .
A number of publications have used polymerase chain reaction (PCR) assays, Southern blotting and in situ hybridization techniques to demonstrate the presence of hPy and SV40 sequences in human tumors (for a comprehensive review see Imperiale, 2000 and references therein). Due to the ubiquitous presence of hPy in human tissues, however, it is difficult to differentiate between their potential causal role in cancer from incidental commensual infections. These studies mostly detect the presence of hPy and SV40 nucleic acid. As TAg is thought to be essential for cellular transformation, a demonstration of its expression in human cancerous tissue would suggest an involvement in cancer.
To assess the expression of the BKV large T-antigen protein in human tissue, we and others have used a monoclonal antibody specific for BK virus large Tantigen generated by Marshall et al. (1991) . Briefly, this antibody was originally generated from the coding region of the carboxy terminus of BKV-TAg which was inserted downstream of the lac Z gene in the bacterial expression vector pU290. The gel purified band corresponding to the fusion protein was excised and the eluted protein was used as immunogen. The resulting antibody reactivity was assessed by using BKV, JCV or SV40 -transformed rodent cell lines demonstrating specificity for BKV-TAg. This antibody did not cross-react with the papovaviral T-antigens, from JCV and SV40, and is commercially available from Chemicon International as ascites fluids (MAB8505). At least two previous studies used this antibody for immunohistochemical and immunoprecipitation studies. Shinohara et al. (1993) applied the antibody to different specimens from a case of malignant lymphoma in which the BK virus infection was confined to the urinary tract in urothelial cells in sites ranging from the renal pelvis to the urinary bladder but not in other tissues from lung, pancreas, brain or the adrenal gland. Flaegstad et al. (1999) employed the antibody to reveal the T-antigen from neuroblastoma lysates.
In the present report, we examined the specificity of this BKV-TAg antibody reaction and report a strong reactivity with uninfected human (but not rodent) cells and tissues. Immunoprecipitation followed by Western analysis and protein sequencing identified the antibody bound cellular protein as the large subunit (Ku86) of the human Ku auto-antigen. End-point dilution and pre-adsorption analysis indicated that the antibody was not mixed and retained its original reactivity in BKVTAg transformed hamster kidney cells. The technical and biological implications of this observation are discussed.
Results
The BKV antibody exhibits a consistent homogeneous reactivity on human cells and tissues Several established human cell lines were observed to show an unsuspected high reactivity to MAB8505 by indirect immunofluorescence. Figure 1a shows representative photographs of DU-145, PC-3, HeLa, CasKi, SiHa cell lines and of human dermofibroblasts (HDF). All the cells showed a consistent nuclear fluorescence. The expression was homogeneous and diffuse throughout the nucleus of cells, although some cytoplasmic fluorescence was also observed. SiHa cells showed particularly high levels of cytoplasmic fluorescence compared to the other cell lines tested. In contrast, rodent cell lines and tissues, such as 3T6 mouse cells (e.g. Figure 1a ), primary mouse tissues and CHO-K1 cells showed no reactivity. Two well-established simian cell lines, CV-1 and COS-7 (data not shown), also showed the human pattern of fluorescence. Thus, 3T6 and CHO-K1 rodent cells were negative and thus represented our negative controls for the molecular characterizations presented below.
The ubiquity as well as the homogeneous pattern of expression revealed by the antibody in all primate cells led us to consider the possibility that the antibody was identifying a cellular antigen, rather than BKV-TAg. To further confirm the fluorescence results, cell extracts from the same cell lines were analysed by Western blotting. A polypeptide with an apparent molecular weight of *86 kDa was detected in all the cell extracts, except 3T6 (lane '3', Figure 1b) . The polypeptide detected also showed slight differences in the electrophoretic mobility among the extracts. Cell extracts from COS-7 and CV-1 cells were also assessed with an anti-SV40 antibody directed against the large Tantigen. As expected, only COS-7 expressed the two SV40 large T-antigen forms previously reported (Simmons et al., 1978) (Figure 1b) . Therefore, the protein detected by the BKV antibody exhibited a pattern of expression consistent with a nuclear, ubiquitous protein and the size similar to papovaviral large T-antigens.
We also examined tissue sections of human liver, prostate and cervix tissues by immunohistochemical or immunofluorescence analysis with the BKV-TAg antibody. Micrographs of sections of different tissues are shown in Figure 2 . The staining or fluorescence of the antibody was nuclear, with none of the normal epithelial cells or malignant cells exhibiting cytoplasmic or membrane immunoreactivity. The staining was diffuse throughout the nucleus of cells and almost all epithelial cells were stained. No staining was noted in negative control tissues or stroma cells from positive 
BKV antibody immunoprecipitates two polypeptides, U and L
We were interested to determine the identity of the cellular protein(s) that are bound by the BKV TAg antibody. Immunoprecipitation of HeLa cell extracts with the antibody revealed the presence of two main polypeptides of *86 and *70 kDa, named hereafter, protein U (upper) and protein L (lower), respectively (Figures 3 and 4a) . As it seemed possible that these peptides were related, we first sought to determine if the second, smaller polypeptide, came from the larger one by proteolytic processing. This was addressed by pulsechase assays on HeLa cells. As Figure 3 shows, even at chase-time 0, both polypeptides were detected in the cell extracts. The two polypeptides followed apparently independent maturation kinetics not consistent with the idea of the maturation of the protein L by proteolytic processing of the protein U. Interestingly, the band U was accumulated in larger amounts in all the chase-times except for the last one where the band L reached the levels of the band U. We then confirmed by Western blotting analysis that the band U is, in fact, the only one recognized by the antibody under Western conditions ( Figure 4a , right panel). After this finding we considered the possibility that both bands, were in fact bound by disulphide bridges to form a heterodimer and that only one of the bands was visualized by Western blotting. Figure 4a shows the Western analysis under reducing and non-reducing conditions, in the presence or absence of dithiothreitol (DTT), respectively. Even in the absence of DTT, both bands were present in considerable amounts. Although the amount of the protein U was considerably reduced, it was still visible by Coomassie blue staining of the membrane. The overexposure of the blot run under non-reducing conditions ( Figure 4a ) revealed a band of *160 kDa. This size is consistent with the molecular mass of a putative heterodimer U+L. The heavy chains of the immunoglobulins (indicated by H in Figure 4a ) remained almost in their totality on top of the lane under non-reducing conditions; they served as an internal control to validate the chemical reaction of the DTT. Therefore, it seemed that the proteins U and L were components of a heterodimer maintained by disulphide bridges and the subunit U harbored the BKV-antibody's epitope under Western blotting conditions. In addition, the maturation kinetics of the band U seemed to be relatively faster than that of the band L and, at any chase-time, the antibody showed considerable high amounts of U and L proteins that were not forming heterodimers.
The band U is the large subunit (Ku86) of the human Ku autoantigen
We next performed a large scale immunoprecipitation of HeLa cell extracts in order to purify sufficient amounts of both proteins to undergo microsequencing reactions. Cell extracts were immunoprecipitated with the antibody, proteins were fractionated by SDS -PAGE electrophoresis and transferred to a PVDF membrane (Figure 4a , left panel). The membrane was stained with Coomassie brilliant blue R-250, the bands were excised and subjected to Edman degradation reactions. The protein L resulted in no sequencing reaction data consistent with N-terminal block; however, the protein U consistently gave sequence data that allowed us to determine its identity. The first 20 N-terminal amino acids (aa) of the band U, were identical to the first 20 aa of the large subunit (Ku86) of the Ku auto-antigen (VRSGN KAAVV LCMDV GFTMS). To confirm the Ku identity, we performed a Western analysis using authentic antibody to Ku86. As Figure 4b shows, the protein U was detected with both the human Ku86 antibody and BKV Tag antibody, therefore they appeared to have the same reactivity. Taken together, these data showed that the polypeptide U corresponds to Ku86 and L, most likely, to the Ku70; both proteins are abundant in the nuclei of cultured cells and can be found either forming a heterodimeric protein of *160 kDa or as free polypeptides. Ku auto-antigen is a cellular heterodimeric protein, composed of 70 and 86 kDa polypeptides, that is abundant in the nuclei of cultured human cells. The band U+L in Figure 4b seems to correspond to the Ku heterodimer. Although the BKV-TAg antibody had been previously reported to be specifically reactive to BKV-TAg in rodent (but not primate) cells, it also seemed possible that the hybridoma clone could have been mistakenly mixed with a Ku86 clone during commercial production. We thus sought to establish the BKV-TAg specificity of the monoclonal antibody.
HKBK-DNA-3 cells are hamster kidney cells transformed by the early region of BK virus. The cells were tested by immunofluorescence, Western blotting and immunoprecipitation in order to detect the expression of large T-antigen. All the cells showed a nuclear fluorescence pattern corresponding to that expected for large T-antigen (Figure 5a) . The SV40 antibody which cross-reacts with the BKV large T-antigen, showed an identical pattern (c, Figure 5a ). Both negative controls consisting of no primary antibody or CHO-K1 cells, revealed no fluorescence (a and d, Figure 5a ). Both the BKV and SV40 antibodies recognized two polypeptides (lanes 2, 4 and 5, Figure 5b ) with apparent molecular weights over the 86 kDa molecular marker, consistent with the size of the BKV TAg forms of 94 and 97 kDa reported previously (Simmons et al., 1978) .
Taken together these results indicate that the BKV monoclonal antibody is able to recognize the viral large T-antigen in a non-human context. In other words, the clone BK.T-1 retained its originally reported reactivity.
A single antibody species is responsible for reactivity to Ku and BKV-TAg
It was important to determine if the commercial ascites fluid we were using was composed of a mixture of two separate antibodies, one reacting to BKV TAg and the other reacting to Ku antigen. To evaluate this, we performed a dilution analysis of antibody reactivity against BKV-TAg expressing cells and compared this to the reaction to Ku antigen in uninfected human cells by ELISA assay on fixed cells, as described in Materials and methods. HeLa cells and HKBK-DNA-3 cells were incubated with twofold serial dilutions of the antibody and evaluated by ELISA (shown in Figure 6a ). Reactivity was seen in both these cell lines in contrast to the CHO-K1 cells that showed no significant reactivity. We then adsorbed the antibody onto fixed HKBK-DNA-3 cells prior to measuring its titer in an end-point dilution assay on HeLa cells. Similarly, the antibody was adsorbed onto HeLa cells and then evaluated on HKBK-DNA-3 cells. As Figure 6b shows, the titer to both cell lines was markedly reduced when the antibody was pre-adsorbed to human cells or BKV-TAg expressing cells. However, no significant reduction in titer was observed if the antibody was pre-adsorbed onto CHO-K1 cells which lack the BKV-TAg. This result supports the conclusion that the commercial antibody preparation is composed of a single antibody species which is reactive to both BKV-TAg and the human Ku antigen.
Discussion
Both SV40 and polyomaviruses have proved to be powerful tools to identify key cellular regulatory proteins and their biological roles. Although large Tantigens have been the subject of exhaustive investigation, their study continues to provide insight into the workings of the cell. The accurate measurement of TAg in tissue, however, is essential for such studies.
In the present work we have evaluated the monoclonal antibody BK.T-1 generated by Marshall et al. (1991) and available from Chemicon International (MAB8505). We have observed that in addition Immunoprecipitates were washed and fractionated by 7.5% SDS -PAGE along with samples from a CHO-K1 cell extract (1) and HKBK-DNA-3 cell extract (2). HKBK-DNA-3 cell extracts were immunoprecipitated with an irrelevant antibody (3), the BKV-TAg (4) or the SV40-TAg antibody (5). Proteins were transferred to nitrocellulose and identified with the BKV antibody by fluorography. Protein molecular weight standards are indicated on the left to reacting to BKV-TAg, this antibody also bound to a cellular protein present in many human cell lines and tissues. Sequence analysis of this bound cellular protein clearly show it to be the Ku antigen. Because of the similar apparent sizes of Ku86 and large T-antigens, however, this antibody is unable to differentiate between Ku86 and BKV-TAg in human tissues and it is therefore of limited utility for any human study.
T-antigens are multifunctional proteins that interact with multiple cellular targets but no cellular homologues of TAg have been described. The interaction of an antibody to large T-antigen with specific domains of cellular proteins could shed light on potentially conserved structural relationships between viral and cellular proteins. It is thus possible that the crossreactivity of the BK.T-1 antibody to both TAg and Ku has biologically important basis and could define a region of common interaction to other cellular factors. Both of these proteins exhibit ATP binding properties and ssDNA-dependent ATPase activities (Fanning and Knippers, 1992; Ochem et al., 1997) and thus may have common interactions with other cellular proteins, for example. The last 70 C-terminal amino acids of the large T protein was the region of protein sequence used as immunogen to generate this monoclonal antibody. Possibly the antibody may be detecting a common epitope, present within those 70 aa and the Ku86 polypeptide. However, significant sequence similarity between BKV large T-antigen and the Ku86 proteins is not apparent when analysed with the CLUSTALW sequence analysis. This sequence analysis suggests that the conserved epitope for antibody binding of these two proteins may not be a simple linear amino acid sequence. However, this result does not preclude the possibility that the putative epitope in common between Ku and TAg is a more structurally complex epitope.
Ku generally appears to exist and function as a heterodimer. This heterodimerization is essential for DNA double-strand breaks (DSBs) repair in vivo and is also important in activating DNA-PK catalytic subunit (Jin and Weaver, 1997) . The BKV antibody reacted predominantly with Ku86 monomers and in a lesser extent with Ku heterodimers, suggesting that the bound epitope may either be subjected to differential conformational properties among monomers and heterodimers, or shielded by the heterodimer. It is also possible that cells have relatively high amounts of Ku proteins in monomeric form relative to the heterodimers and this results in greater reactivity. The genes for the Ku subunits are unrelated and localized in different chromosomes (Cai et al., 1994) , and some reports suggest the Ku proteins may not always exist in its heterodimeric form (Le Romancer et al., 1994; Messier et al., 1993) . Moreover, studies using knockout mice (Nussenzweig et al., 1996; Zhu et al., 1996; Gu et al., 1997; Li et al., 1998) , suggest the possibility that Ku70 and Ku80 may have unique functions which are independent of each other. Future studies will be needed to determine if the common antibody binding properties between BKV-TAg and Ku is biologically significant.
Materials and methods

Cells and antibodies
Cultures were maintained in Dulbecco's modified Eagle's minimum essential medium (DMEM) supplemented with 2 mM glutamine, 1% nonessential amino acids, 100 U/ml A 1/500 dilution of antibody was adsorbed with HKBK-DNA-3 cells (30 min at room temperature) before being evaluated in the titration assay on HeLa cells. Similarly, the antibody was adsorbed with HeLa cells before being evaluated on HKBK-DNA-3 cells. As control, the antibody was adsorbed on CHO-K1 and then evaluated on HeLa and on HKBK-DNA-3 cells; the set of values of the assays were similar and are shown in a single curve. The plots represent the results from three experiments. The standard deviation of each point was calculated and represented as error bars streptomycin, 100 U/ml penicillin, and 10% fetal bovine serum (FBS). Human dermal fibroblasts (HDF) and Chinese hamster ovary (CHO)-K1 cells were generously provided by Dr E Wagner (University of California, Irvine, CA, USA); T3M4 is a pancreas derived cell line provided by Dr Fan (University of California, Irvine, CA, USA). Prostate cancer cell lines DU-145, LNCaP and PC-3 were acquired from American Type Culture Collection (ATCC, Manassas, VI, USA). The monoclonal antibody specific for BK virus large-T antigen (clone BK.T-1) was purchased from Chemicon International (Temecula, CA, USA). SV40 antibody (clone OH9) directed against both the large T and small t antigen, was obtained from Biogenesis Inc. (Brentwood, NH, HSA) . BK virus-transformed cells, HKBK-DNA-3 (Meneguzzi et al., 1981) , were generously provided by Dr Giussepe Barbanti-Brodano (University of Ferrara, Italy).
Western blotting analysis
Cells growing in culture plates were rinsed in ice-cold PBS, scraped and centrifuged at 1500 r.p.m. for 5 min. The cell pellet was lysed in extraction buffer (50 mM Tris×Cl, pH 8, 5 mM EDTA, 150 mM NaCl, 0.5% nonidet-P 40, 0.02% sodium azide, 1 mM PMSF, 1 mg/ml aprotinin, 5 mg/ml leupeptin, 5 mg/ml pepstatin A). Lysates were sonicated at 08C for 1 min and then cleared by centrifugation. Protein concentrations were measured with the Bradford method and 30 mg of total protein were fractionated on 7.5% polyacrylamide gels containing SDS (SDS -PAGE) in Tris/ Glycine/SDS buffer. Following electrophoresis, proteins were transferred to OPTITRAN R nitrocellulose paper (Schleicher & Schuell) in a BIO-RAD transfer apparatus in Tris/Glycine/ 20% Methanol. Western blots were blocked for 1 h at room temperature with I-Block TM (Tropix, Bedford, MA, USA) in PBS-1% Tween-20 (PBST) and then incubated with antibodies diluted 1 : 5000 in I-Block for 1 h at room temperature. The blots were washed three times for 5 min in PBS-T and incubated for 45 min in a 1 : 2000 dilution of secondary antibody (horseradish peroxidase-coupled antimurine IgG from sheep (Sigma) in I-Block. After washing three times in PBST, the blots were incubated with enhanced chemiluminescent (ECL) detection reagent as described by the manufacturer (Amersham). Proteins were detected by autoradiography by exposure of blots to Kodak BioMax ML film.
Pulse-chase experiments and immunoprecipitation
Hela cells were grown on 35 mm dishes to approximately 80% confluence. DMEM media was removed and replaced with media devoid of methionine for 1 h in order to deplete cellular pools of methionine. The medium was removed and fresh methionine-free medium containing 35 S-methionine (80 mCi/ml; Amersham Pharmacia) was added to the dishes for a pulse of 1 h. All plates were then rinsed with DMEM (containing methionine) and refed with this medium for chase time-points. Cells were lysed at specific time intervals in 100 ml of Lysis buffer, sonicated and cleared by centrifugation. Equal amounts (i.e. c.p.m.) of labeled protein were used in immunoprecipitation reactions. Cell lysates were precleared with protein A-agarose beads (Sigma) at 48C for 1 h in an orbital shaker and then incubated with a-BKV antibody (2 ml) at 48C for 1 h. Protein complexes were then collected by incubation for 1 h with 50 ml of Protein A-agarose beads, followed by centrifugation. Immunoprecipitates were washed four times in Lysis buffer, resuspended in Laemli buffer and fractionated by 7.5% SDS -PAGE. Gels were impregnated with intensifying reagent (Amplify, Amersham), dried and exposed to autoradiographic film. Following adequate autoradiograph exposures, densitometric analysis was done using ImageQuant v1.1 software (Molecular Dynamics).
Non-radioactive material immunoprecipitations (Figure 5 experiment) were performed as follows: cells were grown to 80% confluence in T25 flasks and lyzed in lysis buffer (200 ml) as described above. One hundred ml of cell extract were precleared, divided in three tubes and incubated with 2 ml of antibody ascites fluid (irrelevant antibody, BKV-T-Ag or SV40-T-Ag antibody). The volume was brought up to 200 ml with lysis buffer. Precipitation of the protein complexes and SDS -PAGE were conducted as described above. One half of the protein solubilized in Laemli buffer was loaded into each lane. For the experiment of Figure 4a , HeLa cells growing in two T150 flasks were scraped, washed and lysed in 1.2 ml of lysis buffer. One half of the cell extract was subjected to immunoprecipitation reactions in the same conditions described above. All reagent volumes used were increased proportionally. Proteins were transferred to a poly(vinylidene difluoride) (PVDF) membrane (Immobilon-P, Amersham) following the manufacturer's instructions.
N-terminal sequencing
Immunoprecipitated proteins were fractionated by 7.5% of SDS -PAGE. The proteins were transferred to PDVF membrane followed by Coomassie blue staining. The bands were excised manually and processed for microsequencing reactions. Automated Edman degradation was performed on the (PDVF)-immobilized proteins by using an Applied Biosystems (Foster City, CA, USA) Model 477A Protein Sequencer.
Immunoperoxidase labeling of tissue sections
Five m-thick formalin-fixed paraffin-embedded sections were deparaffinized by immersing in xylenes three times for 10 min at room temperature, followed by rehydration of the tissue in decreasing concentrations of alcohol (100, 95, 70, 25% ethanol for 5 min each) and then air dried. Rehydrated sections were immersed in 1 mM EDTA-NaOH, placed in a pressure cooker (BioGenex, San Ramon, CA, USA) and processed in a microwave oven for two consecutive cycles (5 min each) at high (1100 watts) and 40% of level power, respectively. Slides were incubated for 30 min in 0.3% H 2 O 2 in PBS, washed three times in PBS (5 min per wash) and blocked in PBS/BSA for 30 min. Antibodies were diluted in PBS/BSA and applied on tissue sections; typically 1 -2 h incubations were conducted. The sections were washed three times in PBS and incubated with horseradish peroxidasecoupled anti-murine IgG (Sigma), for 1 h. All the incubations were conducted in a humidity chamber at room temperature. Reactivity was visualized with DAB (3,3'-diaminobenzidine tetrahydrochloride) as substrate, yielding a brown reaction product or DAB-Nickel in the presence of 0.05 M Tris×Cl, pH 7.6/0.03% H 2 O 2 , yielding a black color. Harris Hematoxylin (Sigma) or Methyl Green (TACS, Trevigen Inc.) was used as counterstaining. The slides were mounted with Vectamount (Vector Laboratories, Burlingame, CA, USA) mounting medium and observed under light microscope.
Immunofluorescence labeling of tissue sections and cells
Five m-thick cryosections on glass slides were brought to room temperature, and before they air dried, the OCT compound (Sakura Finetek Inc., Torrance, CA, USA) was removed by dipping the slides in decreasing concentrations of alcohol (100, 95 and 75% ethanol) and H 2 O. The sections were layered with PBS and incubated 5 min at room temperature and then blocked at room temperature for 30 min in PBS-1% bovine serum albumin (PBS/BSA). The sections were incubated with a 1 : 200 antibody dilution in PBS-BSA for 1 h at room temperature in a humidity chamber, washed three times in PBS (5 min per wash) and then incubated with a 1 : 100 dilution of secondary antibody (FITC conjugated anti-murine IgG from sheep, Sigma) in PBS/BSA. Slides were then washed three times in PBS (5 min per wash) and mounted with Vectashield (Vector Laboratories Inc, Burlingame, CA, USA).
Cells growing in four-well chambers were washed in PBS warmed at 378C, fixed 5 min in methanol (7208C) and 30 s in acetone (7208C). Incubations, washes and mounting were conducted as indicated above. Fluorescence was observed under a Nikon eclipse TE200 microscope and digital images were collected using identical brightness and contrast settings employing a MagnaFire R SP camera and software (Optronics, CA, USA).
Enzyme-linked immunosorbent assay (ELISA)
Cells were grown to confluence in 96 well microtiter plates and fixed in 80% acetone for 15 min at 48C. Acetone was discarded and plates were air dried at room temperature for at least 1 h. The monolayers of cells were saturated with blocking buffer (0.25% BSA, 1 mM EDTA, 0.05% Tween 20 in PBS) for 30 min at room temperature, incubated with serial dilutions of the antibody (50 ml per well) in blocking buffer for 1 h, and washed three times with PBS/0.05% Tween 20. Then, the cells were incubated for 1 h in a 1 : 2000 dilution of horseradish peroxidase-coupled anti-murine IgG in blocking buffer without Tween 20. The wells were washed three times with PBS and incubated with OPD (ophenylenediamine dyhydrochloride) in citrate/phosphate ELISA buffer. The reaction was stopped with 50 ml per well of H 2 SO 4 3N and absorbance at 492 nm was measured in a THERMOmax microplate reader (Beckman, CA, USA).
